Concurrent preoperative chemotherapy and three-dimensional conformal radiotherapy followed by surgery for oral squamous cell carcinoma: a retrospective analysis of 104 cases

Oncotarget
Lina FanHongbing Lv

Abstract

The objectives of this study were to assess the clinical effects of an integrated program consisting of concurrent preoperative combined paclitaxel and nedaplatin chemotherapy and three-dimensional conformal radiotherapy followed by surgery intended to cure oral squamous cell carcinoma and to determine whether this integrated program is feasible and effective with respect to the treatment of oral squamous cell carcinoma. A total of 104 biopsy-confirmed patients who presented with oral squamous cell carcinoma for the first time were included in this study. Concurrent preoperative combined paclitaxel and nedaplatin chemotherapy and three-dimensional conformal radiotherapy were administered to these patients. The most common treatment regimen consisted of infusions of paclitaxel (135-175 mg/m(2)/day), infusions of nedaplatin (150 mg; 80-100 mg/m(2)/day), and irradiation at doses ranging from 1.5 Gy twice daily to 30-40 Gy over 3-4 weeks. The clinical variables evaluated herein included the local recurrence rate, distant metastasis rate, postoperative survival rate, and degree of mouth opening restriction. The median follow-up time for surviving patients was 60 months, and the median time to progression for all patients was 57.69 m...Continue Reading

References

Aug 6, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·F LohrM Wannenmacher
Jan 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lisa LicitraGiulio Cantù
Jan 20, 2005·Journal of the National Cancer Institute·Peyton T Taylor, Doris Haverstick
Jul 4, 2007·Mayo Clinic Proceedings·Deepak Kademani
Oct 26, 2007·The New England Journal of Medicine·Marshall R PosnerUNKNOWN TAX 324 Study Group
Jan 29, 2008·Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery·Clemens KlugWerner Millesi
Aug 5, 2008·Oral Oncology·Jatin P Shah, Ziv Gil
Jul 26, 2011·Periodontology 2000·Richard J ShawChris Butterworth
Feb 5, 2013·Cancer Chemotherapy and Pharmacology·Hiroyuki HaradaSatoru Shintani
Jul 10, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pierre BlanchardUNKNOWN Meta-Analysis of Chemotherapy in Head and Neck Cancer, Induction Project, Collaborative Group
Jan 10, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P BossiL Licitra
Oct 15, 2014·Journal of the National Comprehensive Cancer Network : JNCCN·David G PfisterUNKNOWN National Comprehensive Cancer Network

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
amputation
dissection
biopsy
surgical resection

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.